Hyper-Personalized Medicine Using Patient Derived Xenografts (PDXovo) for Renal Cell Carcinoma Patients
The Investigators will use novel PDX (patient-derived xenograft) technology to form xenografts using material from metastatic renal cell carcinoma patients. Xenografts will be treated with a panel of drugs to determine which agent(s) yield the greatest anti-tumor effect on the xenograft.
- 0 views
- 09 Jul, 2021
- 1 location